Should a biotech company fund...

In our earlier post on valuation, we had discussed whether one should use the licensor’s or licensee’s cost of capital during out licensing. In this issue, we elaborate on...

Does capital structure play a...

Which side of the balance sheet creates Value? This is an interesting question. While valuing a company, one always tends to focus on equity or debt side. However we forget the...

How do your past investments...

I was working on the valuation of a biotech product in Dec 2012. I was almost done with all the cash flows and discount rates and I was about to calculate the net present value...

Are developing countries an...

The casual answer to this question seems obvious, we would say “Yes”. Markets in these countries offer very favourable growth, usually double-digit, and their populations are...

The Valuation Dilemma: VCs vs...

I had an interesting discussion with one of the biotech entrepreneurs last week. He was curious to see that when he discusses the value of his product with the VCs, he gets a very...

Load More All Post Loaded